BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24857756)

  • 1. Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.
    Stoddard RA; Quinn CP; Schiffer JM; Boyer AE; Goldstein J; Bagarozzi DA; Soroka SD; Dauphin LA; Hoffmaster AR
    J Immunol Methods; 2014 Jun; 408():78-88. PubMed ID: 24857756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid homogenous time-resolved fluorescence (HTRF) immunoassay for anthrax detection.
    Cohen N; Mechaly A; Mazor O; Fisher M; Zahavy E
    J Fluoresc; 2014 May; 24(3):795-801. PubMed ID: 24515915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate and selective quantification of anthrax protective antigen in plasma by immunocapture and isotope dilution mass spectrometry.
    Solano MI; Woolfitt AR; Boyer AE; Lins RC; Isbell K; Gallegos-Candela M; Moura H; Pierce CL; Barr JR
    Analyst; 2019 Mar; 144(7):2264-2274. PubMed ID: 30810119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax.
    Lins RC; Boyer AE; Kuklenyik Z; Woolfitt AR; Goldstein J; Hoffmaster AR; Gallegos-Candela M; Leysath CE; Chen Z; Brumlow JO; Quinn CP; Bagarozzi DA; Leppla SH; Barr JR
    Anal Bioanal Chem; 2019 May; 411(12):2493-2509. PubMed ID: 30911800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel homogeneous immunoassay for anthrax detection based on the AlphaLISA method: detection of B. anthracis spores and protective antigen (PA) in complex samples.
    Mechaly A; Cohen N; Weiss S; Zahavy E
    Anal Bioanal Chem; 2013 May; 405(12):3965-72. PubMed ID: 23388689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures.
    Boyer AE; Gallegos-Candela M; Quinn CP; Woolfitt AR; Brumlow JO; Isbell K; Hoffmaster AR; Lins RC; Barr JR
    Anal Bioanal Chem; 2015 Apr; 407(10):2847-58. PubMed ID: 25673244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of protective antigen, an anthrax specific toxin in human serum by using surface plasmon resonance.
    Ghosh N; Gupta N; Gupta G; Boopathi M; Pal V; Goel AK
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):14-9. PubMed ID: 23773677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
    Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Jan; 15(1):71-5. PubMed ID: 18032590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.
    Corey A; Migone TS; Bolmer S; Fiscella M; Ward C; Chen C; Meister G
    Toxins (Basel); 2013 Jan; 5(1):120-38. PubMed ID: 23344456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
    Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
    J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles.
    Tang S; Moayeri M; Chen Z; Harma H; Zhao J; Hu H; Purcell RH; Leppla SH; Hewlett IK
    Clin Vaccine Immunol; 2009 Mar; 16(3):408-13. PubMed ID: 19129473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.
    Brenneman KE; Doganay M; Akmal A; Goldman S; Galloway DR; Mateczun AJ; Cross AS; Baillie LW
    FEMS Immunol Med Microbiol; 2011 Jul; 62(2):164-72. PubMed ID: 21401726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.